Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why MacroGenics Stock Is Tumbling Today

TheMotleyFool

0 0

Shares of MacroGenics (NASDAQ: MGNX) were tumbling 5.7% lower as of 11:39 a.m. EDT on Thursday. The decline came after the company announced preliminary results from its phase 1 study evaluating MGC018 in treating solid tumors.

MacroGenics said that it saw preliminary signals of anti-tumor activity with MGC018 in treating patients with advanced metastatic castration-resistant prostate cancer (mCRPC). The company reported that reductions in prostate-specific antigens (PSAs) of at least 50% were observed in five patients. Of the nine patients in the study with mCRPC, eight demonstrated stable disease.

Image source: Getty Images.

Source Fool.com

Like: 0

MGNX

Share